Solara Active Pharma Sciences Limited (NSE:SOLARA)
715.00
-10.40 (-1.43%)
Oct 1, 2026, 3:29 PM IST
NSE:SOLARA Market Cap
NSE:SOLARA has a market cap or net worth of 34.49 billion as of October 1, 2026. Its market cap has increased by 18.79% in one year.
Market Cap
34.49B
Enterprise Value
40.85B
Revenue
14.31B
Ranking
n/a
PE Ratio
n/a
Stock Price
715.00
ChartMarket Cap Chart
Since June 27, 2018, NSE:SOLARA's market cap has increased from 6.21B to 34.49B, an increase of 455.24%. That is a compound annual growth rate of 23.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 34.49B | 26.73% |
| Dec 31, 2025 | 27.21B | -16.57% |
| Dec 31, 2024 | 32.62B | 150.91% |
| Dec 29, 2023 | 13.00B | -16.05% |
| Dec 30, 2022 | 15.49B | -57.73% |
| Dec 31, 2021 | 36.63B | -14.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 66.37B |
| Sun Pharma Advanced Research Company | 63.99B |
| Orchid Pharma | 50.57B |
| RPG Life Sciences | 50.23B |
| Ind-Swift Laboratories | 35.92B |
| Sakar Healthcare | 24.96B |
| Indoco Remedies | 24.84B |
| Windlas Biotech | 22.52B |